Home > Insider Trading > Filing (0001062993-22-018004)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1822691	Greenlight Biosciences Holdings Pbc	GRNA	Biological Products, (No Disgnostic Substances) (2836)	851914700

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1908721	Allen Matthew Walker	C/O Greenlight Biosciences Holdings, Pbc 200 Boston Avenue, Suite 3100 Medford MA 02155		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-08-11	63,775	$3.92	63,775	No	4	P	Direct
Common Stock	Acquisiton	2022-08-11	6,377,551	$3.92	22,220,572	No	4	P	Indirect	by Builders Vision, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	by Builders Vision, LLC

Footnotes

Consists of 63,775 shares of Common Stock issued pursuant to a subscription agreement entered into between the Issuer and Matthew Allen Walker.
Includes 6,377,551 shares of Common Stock issued pursuant to a subscription agreement entered into between the Issuer and S2G Builders Food & Agriculture Fund III, LP ("Fund III").
Total number of shares beneficially owned by the Reporting Person includes: (i) 11,551,245 shares held by Fund III; (ii) 2,087,043 shares held by S2G Ventures Fund I, L.P. ("Fund I"); and (iiii) 8,582,284 shares held by S2G Ventures Fund II, L.P. ("Fund II" and, together with Fund I, and Fund III, the "S2G Funds"). Builders Vision, LLC is the Manager of Fund I and Fund II, and the General Partner of Fund III, and has power to vote or direct the voting of shares held by the S2G Funds. The General Partners of Fund I and Fund II are S2G Ventures, LLC and S2G Ventures II, LLC, respectively.
(Continued) Mr. Walker, a director of the Issuer, is a Managing Director of Builders Vision, LLC, the impact platform founded by Lukas T. Walton, which includes S2G Ventures. By virtue of the foregoing, S2G Ventures, LLC and S2G Ventures II, LLC, Mr. Walker and Mr. Walton may be deemed to indirectly beneficially own (as defined in Rule 13d-3 of the Exchange Act) the shares of Common Stock held by the S2G Funds. Mr. Walker and Mr. Walton each disclaims beneficial ownership of these shares of Common Stock except to the extent of any pecuniary interest therein.